Integrating Git version control with validation systems automates medical device software traceability, ensuring instant ...

The webinar highlights opportunities in enhancing system validation, utilizing agile and waterfall methodologies, and leveraging COTS, SaaS, IaaS, PaaS, and cloud solutions to meet FDA requirements ...

Market opportunities lie in modernizing software development and validation approaches, emphasizing agility and continuous validation to meet changing needs, while ensuring compliance with FDA ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

The burgeoning field of Software as a Medical Device (SaMD) offers opportunities for innovation in healthcare monitoring and delivery through mobile apps. Regulatory focus by the FDA on "device ...

Austin, Texas, United States, November 5th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT) has been initiated with a Buy rating ...

FDA says Philips devices from U.S. plants were adulterated due to poor manufacturing and oversight, adding to the company's ...

A DevOps-based framework integrates automation, continuous integration, and agile methodologies to enhance medical device software development. By embedding compliance verification, automated testing, ...

As drug development enters a new era, Certara is expanding its global team of scientists and technologists to lead the shift toward AI-powered testing methods.

Initiated With Buy Rating And $4 Price Target By Roth Capital. HeartBeam (NASDAQ: BEAT) has been initiated with a Buy rating and $4 price target by Roth Capital Partners, which highlighted the compan ...

FDA finds widespread quality issues at three Philips medical device facilities, citing violations in manufacturing and complaint handling.

The Global Digital Pathology Market is projected to grow from USD 1.15 billion in 2024 to USD 6.55 billion by 2035, ...